Stock Taper
OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS
MENS
JYONG BIOTECH LTD. ORDINARY SHARES
NASDAQ
$2.06
▼ DOWN 0.96% (-0.02)

KEY STATISTICS

Market Cap$156.62 M
52w High$64.60
52w Low$1.43
Dividend Yield—
Frequency—
P/E-34.33
Volume19.70K
Shares Out.76.03M

COMPANY

LEADERSHIP

Fu-Feng Kuo
CHIEF EXECUTIVE
Fu-Feng Kuo

ABOUT

SECTOR
Healthcare
WENT PUBLIC
June 17, 2025
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
27

PRICE

$2.06 ▼ DOWN 0.96% (−$0.02)
$2.08$2.12$2.169:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM2.06

About Jyong Biotech Ltd. Ordinary Shares

https://www.jyongbio.com/ ↗

Jyong Biotech Ltd., a Taiwan-based biotech firm, develops plant-derived drugs for urinary diseases, with key candidates like MCS-2 (Phase III) and PCP (Phase II), through subsidiaries including Health Ever Bio-Tech and Genvace.

INDUSTRY

Biotechnology

A PRODUCT JYONG BIOTECH LTD. ORDINARY SHARES IS KNOWN FOR

MCS-2
MCS-2

MCS-2, Jyong Biotech's flagship plant-derived softgel drug candidate for BPH and LUTS, is currently undergoing NDA review with the U.S. FDA.

COMPETITORS

COMPETITOR
BIOA COMPARE
CGEM COMPARE
CMPS COMPARE
KURA COMPARE
PRME COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
11
LISTED HERE
5
RANKED BY POSITION SIZE
IBB
0.00% · 220.0K
ONEQ
0.00% · 26.7K
SBIO.MI
0.01% · 24.0K
203780.KS
0.01% · 3.8K
BIB
0.01% · 2.5K

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

SECTORS PEERS

PEERPRICE
APGE$135.07COMPARE
CGON$74.62COMPARE
TVTX$62.76COMPARE
CELC$80.61COMPARE
XENE$39.75COMPARE
LEGN$17.61COMPARE
DYN$17.11COMPARE
RARE$14.51COMPARE